Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that its Board of Directors has decided to explore potential financial and strategic alternatives intended to enhance stockholder value. The Company has engaged Canaccord Genuity LLC as its financial advisor. The overall uncertainty, the restriction on elective procedures and the specific directives issued by the Governor of California regarding Covid-19 has had an immediate impact on Obalon’s business.
Providence St. Joseph Health announced Wednesday it has acquired HMR (Health Management Resources), an established provider of clinically proven weight-loss programs, from Merck. The addition of a comprehensive weight management service to Providence’s suite of health services is the latest example of the non-profit health organization’s efforts to improve the health and well-being of patients and communities. According to HMR President Len Tacconi, HMR’s specialty is using behavior-change techniques to help patients who have significant weight to lose learn the lifestyle skills that matter most for better health and quality of life. A positive relationship between Providence and HMR has existed for several years. HMR operates clinics inside three Providence facilities, while Providence refers its caregivers to HMR for weight management support and care as part of its employee wellness program.
DuneGlass Capital, a growth-oriented investment firm focusing on partnering with entrepreneurs, today announced that it has partnered with Grand Health Partners, a leading provider of comprehensive medical and surgical weight loss solutions headquartered in Michigan. Terms of the partnership were not disclosed. “Grand Health Partners is a leader in the bariatric space, offering a comprehensive approach to weight loss through registered dietitians, exercise physiologists, and behavioral experts, in addition to scientifically proven medical and surgical interventions performed by board-certified bariatricians and surgeons,” said Dan Hosler, Managing Partner at DuneGlass Capital. “When we first met senior partners Drs. Baker and Kemmeter and saw GHP’s approach to comprehensive patient care, we knew right away we wanted to partner with them to facilitate and expand on their vision for growth.”
Noom, the world’s leading behavior change company, today announced it has received an investment from Serena Ventures to help fund the company’s continued growth. In addition to capital, Noom will have access to the firm’s expansive network and growing list of portfolio companies. Noom’s clinically-proven programs combine compassionate human coaches with modern technology and psychology to provide customized support, guidance, and motivation for each person’s weight loss journey. Noom has spent the last decade working with over 50 million users in order to perfect its proprietary behavior change programsÑall designed to drive meaningful health outcomes and lasting lifestyle changes that improve lives and lower healthcare costs.
What We Do
Who We Are
How We Work
Who We Help
Get In Touch
Connect With Us
Subscribe to Our Daily Note
We publish a Daily Note that aggregates M&A activity, notable developments, regulatory changes, and conferences we deem to be of interest to our partners. It is a quick afternoon read and an easy way to keep your finger on the pulse of the healthcare space. Please fill in your name and email address below if you wish to subscribe.